Statement Of Comprehensive Income [Abstract]

Xbrane Biopharma - Filing #689992

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Statement of comprehensive income [abstract]
Profit (loss)	—	172 513 SEK	—	172 513 SEK	—	—	—	—	188 376 SEK	188 376 SEK
Other comprehensive income [abstract]
Other comprehensive income	—	5 157 SEK	—	—	5 157 SEK	—	—	1 220 SEK	1 220 SEK	—
Comprehensive income	– SEK	167 356 SEK	– SEK	172 513 SEK	5 157 SEK	– SEK	– SEK	1 220 SEK	187 156 SEK	188 376 SEK
Comprehensive income attributable to [abstract]
Comprehensive income, attributable to owners of parent	—	167 356 SEK	—	—	—	—	—	—	187 156 SEK	—
Comprehensive income, attributable to non-controlling interests	—	– SEK	—	—	—	—	—	—	– SEK	—